Background pacemaker (PMK) implantation is a routinary procedure although it isn’t free from complications, some of with could be life–treathing. Case report: A female 84 years old with hypertensive cardiomiopathy and atrial fibrillation on anticoagulation theraphy with Dabigatran was subjected on a pacemaker implantation (29th Sept) for sick sinus syndrome (SSS) after syncope. The day after the implantation a chest radiography showed a left–apical pneumothorax (PNX) without necessity of surgical drain (fig. 1). Few days after (3th Oct) patient showed dyspnoea, desaturation and pain on left hemithorax so a chest CT was performed with detection of massive hydropneumothorax needed surgical drain. After 5 days a check CT was performed (9th Oct) showing resolution of the PNX but documented a circumferential 30 mm pericardial effusion “worthy of cardiological reevalutation” meanwhile the patient was hemodynamically stable. At echocardiographic look there was a pericardial effusion of 15 mm. After the re–evalutation of the CT imeges by a cardiologist, in the suspicion of myocardial perforation, patient were centralized in a cardio–surgery center. Transesophageal echocardiography evidenced a pericardial effusion of 19 mm with initial signs of haemodynamic impact and visualization of the lead in the percardual sac by 15 mm. The patient underwent (11th Oct) extraction of the ventricular lead in median sternotomy and epicardial reimplantation in a hybrid arrhythmological and cardiosurgery operating theater. Conclusions cardiac perforation and PNX are two serious but rare complication of PMK implantation with an incidence of 0,1% and 1%, but only anecdotally described together in the literature. The initial finding of PNX which was attributed the syntomatology was a confounding factor that delay the diagnosis of miocardial perforation. The unavailability of a programmer for interrogating the device didn’t allow early documentatio of the alteration of the electrical parameters. In the first CT of 3th Oct no pericardial effusion were reported but, from a retrospective analysis the images were alredy suggestive while they leave no doubts in the second radiological examination (fig 2,3).
Background Provide a brief overview of recent technological advances that can potentially give information for treatment of different kind of arrhythmias. Methods In this report, we describe the features of Omnipolar technology (OT) using high density mapping catheter and we report five different scenario in which this new tool can give some important information to understand arrhythmia’s substrate and guide the treatment. OT combine three unipolar and two bipolar signals and provides maximum voltage regardless of electrode-wavefront orientation, local wavefront activation direction and local measurements of wave speed: it allow to create a velocity map. Results OT has been used to study different types of supraventricular tachycardias. Regarding reentry tachycardias, velocity map has allowed the characterization and definition of the impulse velocity along the dual nodal pathway and the accessory pathways (AP). As regards atrial flutter, it has successfully allowed the definition of the slowest zone of the critical isthmus and radiofrequency (RF) delivery at that point resulted in termination of the arrhythmia. During mapping of the left atrium in sinus rhythm, the velocity map allowed the identification of the course of the Bachmann’s bundle, which could potentially play a role during the ablation of persistent atrial fibrillation (AF). Conclusion OT and velocity map offer significant advantages in the management of challenging arrhythmias, and can potentially improve the efficacy of the treatment of some arrhythmias such as atrial flutter and AF.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.